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Abstract 
 
Vetsuisse Faculty University of Zurich (2019) 
 
Florian Johannes Strasser 
 
Department for Farm Animals, Clinic of Reproductive Medicine 
cgeisinger@vetclinics.uzh.ch 
 
Pathogen-specific changes of milk composition and lack of effect of high 
dosage oxytocin during mastitis in dairy cows 
 
The objective of the present study was to investigate changes of the blood derived 
milk components somatic cell count (SCC), lactate dehydrogenase (LDH) and 
especially immunoglobulin G (IgG) in milk of cows suffering from mastitis caused by 
different pathogens. In addition, we have investigated the effects of repeated i.v. 
injections of a high dosage of oxytocin (OT; 100 IU) on these parameters. Therefore, 
milk samples from all udder quarters of 184 dairy cows from several dairy farms were 
collected at day 1, which was the day of the clinical examination and diagnosis of 
mastitis and days 2, 3, 14 and 28. Bacteriological examination on day 1 detected 
involved pathogens. Cows were randomly assigned into treatment group (OT 
injections on days 1 and 2) and control group (no OT). Changes of SCC, LDH and 
IgG were shown to be pathogen dependent. Highest values of all three parameters 
were measured in mastitis caused by Streptococcus uberis. The changes were less 
pronounced in mastitis cases with other Streptococci spp., Staphylococci spp. or 
Corynebacterium bovis. Oxytocin treatment did not affect any parameter from days 1 
to 3 independent of the pathogen. Only in quarters infected with other Staphylococci 
than Staphylococcus aureus a decreased SCC was observed between days 2 and 
14 as well as an increase of IgG in quarters, where no pathogens were detected. 
Thus, a high dosage of OT as a treatment for mastitis is obviously not sufficient. 
Key words: dairy cow, mastitis, oxytocin, pathogen specifity 
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Zusammenfassung 
 
Vetsuisse-Fakultät Universität Zürich (2019) 
 
Florian Johannes Strasser 
 
Departement für Nutztiere, Klinik für Reproduktionsmedizin 
cgeisinger@vetclinics.uzh.ch 
 
Pathogen-spezifische Veränderungen in der Milch und Einsatz von hoch-
dosiertem Oxytocin zur Therapie von Mastitiden bei Milchkühen 
 
Ziel der Studie war die Erfassung pathogenabhängiger Veränderungen der somati-
schen Zellzahl (ZZ), der Laktatdehydrogenase (LDH) und von Immunglobulin G in 
der Milch von Kühen, die an Mastitis erkrankt waren. Ausserdem wurde der Effekt 
einer mehrfachen i.v. Injektion von hochdosiertem Oxytocin (OT; 100 IU) auf diese 
Parameter analysiert. Dazu wurden 184 Kühe aus verschiedenen Milchviehbetrieben 
entweder der Behandlungsgruppe mit OT Injektion an den Tagen 1 und 2 oder der 
Kontrollgruppe ohne OT Behandlung zugeordnet. Milchproben aller Euterviertel 
wurden an Tag 1, an dem auch die klinische Untersuchung und Diagnose erfolgte, 
sowie an den Tagen 2, 3, 14 und 28 genommen. Mit Hilfe einer bakteriologischen 
Untersuchung an Tag 1 wurden die Pathogene ermittelt. Die Veränderungen von ZZ, 
LDH und IgG waren pathogenabhängig. Die jeweils höchsten Werte wurden bei 
Streptococcus uberis gemessen. Sie waren weniger stark verändert bei anderen 
Streptococci spp., Staphylococci spp. oder Corynebacterium bovis. Unabhängig vom 
verursachenden Pathogen bewirkten die OT Behandlungen keine Veränderungen 
der untersuchten Parameter an den Tagen 1 bis 3. Lediglich bei Infektionen mit 
anderen Staphylococci als Staphylococcus aureus konnte ein Rückgang der ZZ 
zwischen Tag 2 und Tag 14, sowie ein Anstieg von IgG in der Milch der nicht 
infizierten Viertel beobachtet werden. Eine Therapie mit hochdosiertem OT bei 
Mastitiden ist deshalb als nicht ausreichend zu bewerten. 
Stichwörter: Milchkuh, Mastitis, Oxytocin, Pathogenspezifität 
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Pathogen-specific changes of milk composition and lack of effect of high 
dosage oxytocin during mastitis in dairy cows  
 
Authors 
F.J. Strasser, M. Feldmann, J.J. Gross, A.T.M. Müller, H. Pfingstner, S. Corti, R. 
Stephan, H.  Bollwein, R.M. Bruckmaier, O. Wellnitz 
 
 
INTRODUCTION 
 
In dairy cows, many different pathogens can cause clinical and subclinical mastitis. 
During an infection of the mammary gland, milk composition usually changes. To 
achieve high standards of milk quality in dairy farming, mastitis is commonly treated 
with antibiotics. As the use of antibiotic treatment in food producing animals is 
progressively losing acceptance due to the possible selection of resistant pathogens 
as well as the possible occurrence of residues, the goal is to reduce antibiotic usage 
in veterinary practice. Furthermore, the animal´s own immune system should be 
promoted to cope with invading pathogens. However, non-antibiotic mastitis treat-
ment is usually adjusted to the severity of mastitis rather than to the pathogens 
involved, e.g. anti-inflammatory medication or pain management. With increasing 
knowledge on pathogen specific effects of non-antibiotic treatments, their efficiency 
and appropriate use could be optimized. 
Oxytocin (OT) is a hormone, which is released from the pituitary gland in 
response to teat stimulation by the calf or the milking machine (Crowley and 
Armstrong, 1992; Bruckmaier and Blum, 1998). It causes contraction of myoepithelial 
cells, which surround the alveoli formed by the milk secreting epithelial cells. This 
contraction leads to milk ejection (Soloff et al., 1980). In veterinary practice OT 
administration at a supraphysiological dosage is used to induce a maximum possible 
milk ejection. The positive effect on mastitis cure was suggested to be due to the 
promotion of complete udder emptying, which leads also to a removal of the bacteria 
(Knight et al., 2000). Exogenous OT administered at an extremely high supraphysio-
logical level up to 100 IU was previously shown to increase the permeability of the 
blood-milk barrier (Allen et al., 1990; Wall et al., 2016). The mechanism behind this 
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phenomenon is supposed to be a partial breakdown of the tight junctions between 
neighboring mammary epithelial cells (Linzell and Peaker, 1971). Furthermore, OT 
has recently been reported to induce mammary epithelial disruption and epithelial cell 
exfoliation (Herve et al., 2018).  
The increased permeability of the blood-milk barrier is characterized by the 
appearance of blood constituents in milk because of the facilitated paracellular 
diffusion of blood and milk constituents (Nguyen and Neville, 1998). The blood 
constituents that are transferred from blood into milk include the protein serum 
albumin (SA) and the enzyme lactate dehydrogenase (LDH; Stelwagen et al., 1994; 
Lehmann et al., 2013). Their increasing appearance in milk has, therefore, the 
potential to be used as a marker for an increased permeability of the blood-milk 
barrier. In addition, immunoglobulins (Ig) are increasingly transferred from blood into 
milk through an impaired blood-milk barrier (Lehmann et al., 2013). In milk these Ig, 
specifically IgG, are supposed to have functional properties during a mammary 
immune response (Burton and Erskine, 2003). The increase of IgG-transfer into milk 
could, therefore, enhance the immune competence of the mammary gland if 
antibodies against mastitis pathogens are present in the blood, i.e. in vaccinated 
cows and, could improve the cure rates of mastitis.  
A recent study showed that the administration of OT in supraphysiological 
doses causes an increase of the somatic cell count (SCC) in milk of healthy cows 
and also in cows with induced mastitis by endotoxins from Gram-negative and Gram-
positive bacteria (Wall et al., 2016). These are mainly cells of the innate immune 
system (Sarikaya et al., 2004) which have significant effects in combatting against 
udder pathogens (Burton and Erskine, 2003). Therefore, a pronounced increase of 
SCC during mastitis by OT application could improve the elimination of pathogens. 
The effects of high dosages of OT on SCC and the blood-milk barrier perme-
ability were shown to be pathogen specific (Wall et al., 2016). Therefore, it is likely 
that effects of mastitis treatment with OT is pathogen dependent. Until now pathogen 
dependent changes of milk composition including the antibody content in milk during 
mastitis after OT administration were mainly investigated in experimental models with 
pathogen associated molecular patterns (PAMP; Wellnitz et al., 2011; 2013). Never-
theless, little is known on effects of OT on changes of the blood-milk barrier and SCC 
during mastitis with different live pathogens. Therefore, the aim of the present study 
was to investigate changes in concentrations of blood-derived components like SCC, 
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LDH, and IgG in milk of cows with naturally occurring mastitis caused by different 
pathogens, treated with or without intravenous administration of high dosages of OT. 
 
 
MATERIALS AND METHODS 
 
Animals 
In 2017, lactating Simmental cows (n=184) with signs of mastitis like clots and flakes 
in milk, painful and swollen udder quarters with or without disruption of general 
condition or only an increased SCC without further symptoms were presented to two 
veterinarian practices in Zachenberg, Germany, and Oberkappel, Austria. The 
domains of the practices were located in a distance of less than 100 km from each 
other. Climatic conditions and feed ingredients for dairy cows were comparable 
among farms. The cows included in the present study were housed on 59 farms with 
a size of four to 200 dairy cows, equally distributed in different housing forms: all year 
tie stall housing, all year free stall housing, free stall and pasture, tie stall and 
pasture, or a combination of tie and free stall. Cows were included in the study if they 
were less than 250 DIM, and had no mastitis treatment in the last four weeks. Cows 
were not vaccinated against mastitis pathogens. The study was approved by the 
District Government of Upper Bavaria, Germany (registration number: AZ 55.2-1-54-
2532-4-2017) and the Office of the Upper Austrian State Government, Austria 
(registration number: Ges-2016-409034/5-Ho). 
 
Experimental Design 
 After diagnosis and a careful clinical examination on day 1 general condition, body 
temperature, changes in udder condition or milk quality, and other significant findings 
were recorded and cows were further examined on days 2, 3, 14 and 28.  
Cows were randomly assigned to the treatment group (OT; n = 101) or to the control 
group (n = 83). 
Milk samples from all four quarters were collected on days 1 (prior to the 
treatment), 2, 3, 14, and 28. Immediately after sampling, cows of the treatment group 
(OT) received 100 IU of oxytocin intravenously on days 1 and 2. These cows were 
not milked before, or immediately after the injections. If the mastitis was acute, i.e. 
cows showed clots or flakes in the milk and the general condition of animals was 
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affected, cows were treated independently of the assigned experimental group 
according to the common therapy protocol of the veterinary practice (including 
antibiotic treatment), directly after collecting the samples on day 1. If possible, i.e. if 
the general condition was not impaired, cows were not treated, until the result of the 
bacteriological examination of the milk sample was available. The cows were not mil-
ked after the oxytocin injection before the next scheduled milking. 
 
Laboratory Analyses 
On days 1, 2, 14, and 28 the SCC was measured in the milk samples with a DeLaval 
cell counter (DCC; DeLaval, Tumba, Sweden) immediately after sampling. Measure-
ments above 3 × 106 cells/mL were recorded as >3 × 106 cells/mL as the detection 
limit for the counting device is between 3 - 4 × 106 cells/mL. Results were log-trans-
formed (log10) to assure normal distribution and to take into account that higher cell 
counts above the detection limit could not be captured. On day 3 SCC was solely 
estimated with a California Mastitis Test (CMT; Schalm and Noorlander, 1957). After 
SCC measurement milk samples were stored for further analyses at -20°C. 
For the measurement of LDH activity milk serum was obtained by centrifugation 
of the milk samples at 1,900 x g for 15 min at 4 °C and then at 20,800 x g for 30 min 
at 4 °C. The LDH activity was determined using the commercial kit AXON00025 
(Axon-Lab AG, Baden, Switzerland) using an automated analyzer (Cobas Mira, 
Roche Diagnostics, Basel, Switzerland) according to the manufacturer’s protocol.  
Milk samples from 299 quarters of 97 cows were selected for the measurement 
of IgG concentrations. These cows were either treated with OT (n= 57) or used as 
controls with no OT treatment (n=40). The IgG concentrations were measured by 
ELISA kit No. E10-118 (Bethyl Laboratories, Montgomery, TX) according to the 
manufacturer`s instructions. For the absorbance measurement a Synergy Mx plate 
reader (BioTek Instruments, Winooski, VT) was used. The inter- and intra-assay 
coefficients of variation were 4.8% and 8.9%, respectively.  
Bacteriological examinations of the milk samples from days 1 and 28 were 
performed according to standard procedures (Anonymous, 1999). 
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Statistical Analysis 
Quarters were grouped by pathogens based on their quarter milk bacteriological 
results on day 1. Results are presented as lsmeans ± SEM. Statistical analyses were 
performed by using SAS (SAS version 9.4 SAS Institute Inc., Cary, NC).  
The general linear models (GLM) procedure was used to test the effects of 
treatment, day, and pathogen. Correlation between LDH and SCC, and IgG and LDH 
were evaluated by the CORR procedure. Differences of means of IgG concen-
trations, SCC, and LDH activity in milk between treatment days and bacteriological 
negative and infected with Gram-positive bacteria were tested for significance using 
paired t-test procedure. For SCC and LDH quarters were grouped by treatment (with 
or without OT treatment) and by pathogens. To test differences in IgG concentrations 
between days quarters infected with Gram-positive bacteria in which IgG was 
measured were merged to one category to increase the number of observations as 
IgG was not measured in all samples. Differences were considered significant when 
P < 0.05.   
 
 
RESULTS 
 
Pathogens and SCC  
Detected pathogens and the SCC in affected quarters on day 1 are shown in table 1. 
Results were obtained from 700 quarter samples. In 539 quarters, there was no 
pathogen detectable. In 61% of these quarters the SCC was above 100,000/mL and 
in 14% of these quarters the SCC above the detection limit of the DCC system 
(3,000,000/mL). Pathogens were found in 161 quarters, thereof 82 quarters were 
treated with oxytocin. 
The SCC on days 1, 2, 14, and 28 in quarters infected with different pathogens 
with and without OT treatments are shown in table 2. As SCC values that were at or 
above detection limit were calculated as 3,000,000 cells/mL the results were logarith-
mized (log10) and the number of samples with SCC at or above 3,000,000 cells/mL 
in each group is also shown on table 2. The OT treatment, the day, and the pathogen 
influenced the SCC (P < 0.05, <0.001, <0.001, respectively). However, only in quar-
ters infected with other Staphylococcus than Staphylococcus aureus a significant 
decrease (P < 0.05) of the SCC between days 2 and 14 was detectable with OT 
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treatment. In control quarters that were not treated with OT there was no significant 
change (P=0.54) of SCC between day 2 and day 14 detectable. The SCC means of 
groups treated with OT compared to groups without OT treatment on day 1 within 
pathogen was not different except in Streptococcus uberis infection. The CMT results 
on day 3 were between ++ and +++ in quarters infected with the different pathogens. 
The results of CMT within pathogens were not different between treatment with or 
without OT. 
 
LDH activity in milk 
Mean LDH activity measurements in milk from quarters infected with different patho-
gens within treatment group on the different days are shown in table 3. LDH activity 
in milk was positively correlated (P<0.05) with SCC in infections with all different 
pathogens except in quarters infected with Staphylococcus aureus. Highest LDH 
activities were found in milk samples of glands infected with Gram-negative bacteria 
and with Streptococcus dysgalactiae and Streptococcus uberis. The OT treatment 
had no effect on LDH concentrations, whereas the day and the pathogen had 
significant effects on LDH concentrations in milk (P < 0.001). 
The Pearson correlation coefficients between LDH activity and IgG concen-
trations over all samples on the first three days in milk were 0.54 (P=0.007), 0.61 
(P<0.001), 0.97 (P<0.001), 0.89 (P<0.001), and 0.01 (P=0.295) in quarters infected 
with Corynebacterium bovis, Staphylococcus aureus, other Staphylococcus, 
Streptococcus uberis and in quarters where no pathogens were detected, 
respectively. 
 
IgG concentrations  
Mean IgG concentrations in milk of quarters infected with different pathogens within 
treatment group on the different days are shown in figure 1. If cows were treated with 
OT the IgG concentration in the 128 quarters with negative bacteriological results 
changed (P < 0.05) from concentrations between 0.13mg/mL and 3.14mg/mL on 
day 1 to concentrations between 0.31mg/mL and 2.65mg/mL on day 2. There was no 
further change of IgG concentrations on day three. In quarters of OT treated cows 
that were diagnosed with Gram-positive bacteria the IgG concentrations ranged from 
0.16 mg/mL and 11.24 mg/mL on day 1 and did not significantly change on day 2 or 
day 3. 
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Highest IgG concentrations were measured in a quarter that was infected with 
Staphylococcus spp. (11.24 mg/ml and 11.68 mg/mL on day 1 and day 2, respect-
tively). Very high IgG concentrations were measured in quarters infected with 
Streptococcus uberis (up to 10.99 mg/mL). In these measurements three quarters of 
one cow that was in the 9th lactation were included. IgG concentrations were not 
measured in quarters infected with Escherichia coli. 
OT treatment did not have an effect on IgG concentrations on days 2 and 3 within 
groups of involved pathogens (see figure 1). 
 
 
Other symptoms 
All cows with Escherichia coli infection had increased rectal temperature above 
39.5 °C. Furthermore, 22.7% of cows infected with Streptococcus uberis, and 17.6 % 
of cows infected with Streptococcus dysgalactiae developed this temperature 
increase. In all other infections less than 12% of cows developed a rectal tempera-
ture above 39.5 °C. 
Clots and flakes were found in milk from all Escherichia coli infected quarters. 
Fewer quarters with flakes were found in Streptococcus uberis (57.7%), 
Streptococcus dysgalactiae (52.9%) and other Staphylococcus (44.4 %), and lowest 
numbers of quarters with flakes were found in Staphylococcus aureus infections 
(31.4%). 
In the OT treatment group 9, 10, 3, 6, and 3 quarters and in the control group 4, 
3, 5, 5, and 11 quarters infected with Corynebacterium bovis, Staphylococcus 
aureus, Streptococcus dysgalactiae, other Staphylococcus spp., Streptococcus 
uberis, respectively, were treated with antibiotics.  
 
 
DISCUSSION 
 
Different mastitis pathogens were detected in milk from dairy cows in the present 
study. The main bacteria that induced mastitis were Streptococcus uberis, Staphylo-
coccus aureus, and other Staphylococci. This represents the expected distribution of 
mastitis pathogens in dairy farming throughout Europe (Heikkilä et al., 2018). It also 
shows that Streptococcus uberis is increasingly a significant inducer of mastitis 
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compared to older studies (Tenhagen et al., 2006). Interestingly, 61% of the quarters 
in which no pathogens were detected had an SCC above 100,000 cells/mL, and 14% 
of these bacteriological negative quarters had an SCC above the detection limit of 
the used device, which is at 3,000,000 cells/mL. According to the German Veterinary 
Medical Society (DVG, 2009) an SCC below 100,000 cells/mL in quarter foremilk 
samples is in the physiological range and with increasing SCC above 
100,000 cells/mL the likelihood of an existing mastitis increases. As only standard 
methods for bacterial detection were used in this study, it is possible that quarters 
were infected with pathogens that are not captured with these methods, e.g. 
Mycoplasma. Furthermore, Hill (1981) showed that in severe mastitis induced by 
Escherichia coli the bacteria are often eliminated from the mammary gland that only 
endotoxin and no live bacteria can be found in mastitic milk. Therefore, in the 
quarters from which sterile milk samples were received, Gram-negative bacteria 
might have had induced an inflammation but they were already eliminated by the 
immune system of the mammary gland. Other reasons for not detecting bacteria in 
milk from infected mammary glands could be the varying shedding of bacteria into 
the milk as it is seen for example in Staphylococcus aureus infections (Walker et al., 
2011). 
Independently from the involved pathogen SCC, LDH, and IgG was not 
influenced by OT treatment from the first to the second day of investigation. Except a 
decreased SCC in quarters infected with other Staphylococci than Staphylococcus 
aureus was seen after two weeks with OT treatment. It was shown before that the 
SCC increased in healthy quarters after injection of 100 IU OT (Wall et al., 2016). In 
addition, in quarters which were immunologically stimulated by intramammary appli-
cation of the endotoxin lipopolysaccharide from Escherichia coli or with lipoteichoic 
acid from Staphylococcus aureus the high dosage of OT further increased the SCC in 
addition to the increase in response to the endotoxin challenge. However, in these 
experimentally induced immune responses, the mammary glands were healthy 
before the start of experiment. It is likely that a pronounced increase of SCC could 
not be detected in the present study because the cows in this study were presented 
to the veterinarians and first sampling occurred when first symptoms were detected 
by the farmer. At that time the increase of SCC was already triggered and in process. 
When exactly the invasion of the pathogens occurred is not known, and the first 
sampling was, therefore, performed at different stages of mastitis. Another reason for 
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not detecting a pronounced SCC increase after OT injection in spontaneous mastitis 
compared to experimental induced mastitis could be that the concentration of 
intramammarily applied endotoxins within the mammary gland continuously de-
creases beginning immediately after infusion with ongoing milk synthesis. In contrast, 
live bacteria are continuously multiplying which represents an ongoing and increasing 
immune challenge. This progeny of bacteria is pathogen specific (Bannerman et al., 
2004) and is accompanied with a pathogen specific pattern of SCC increase. At 
which stage of mastitis the sampling and the OT injection was performed cannot be 
determined. 
The intravenous application of 100 IU oxytocin to dairy cows was expected to 
pronounce the opening of the blood milk barrier, and to increase, therefore, not only 
the SCC, but also the IgG content in milk (Wall et al., 2016). Antibody binding to 
bacteria opsonizes pathogens to facilitate the phagocytosis by leukocytes 
(Targowski, 1983). Therefore, the increase of IgG in milk during mastitis could 
support the combat against the involved pathogens if specific antibodies would be 
available in the blood (Burton and Erskine, 2003), e.g. after previous contact with the 
pathogen or after vaccination. In this field study, the treatment of dairy cow mastitis 
with 100 IU oxytocin intravenously did not show significant effects on the increase of 
IgG after the treatment. Only in healthy quarters, an increase of IgG by OT treatment 
was detected. Concentrations of IgG and their increase in milk during an ongoing 
mastitis are very individual (Wall et al., 2016). This was also seen in varying con-
centrations on day 1 in this study. Furthermore, as already discussed for SCC, the 
first sampling was performed at different stages of mastitis, which can mask a further 
increase of IgG transfer from the blood. 
It is known that different bacteria induce the mammary immune response dif-
ferently, which leads to a different expression of immune factors in the mammary 
gland and to different concentrations of several immune factors and blood compo-
nents in milk (Bannerman et al., 2004; Wellnitz and Bruckmaier, 2012). In the present 
study highest values of SCC, LDH, and IgG were measured in Streptococcus uberis 
infected quarters. Very high concentrations of IgG in milk of Streptococcus uberis 
infected quarters of one cow in the 9th lactation were found. It is known that IgG1 
concentrations in serum increase after the third lactation (Caffin et al., 1983); there-
fore, the age of this cow could be one of the reasons for the high IgG concentrations. 
It is also known that IgG decreases throughout lactation (Musayeva et al., 2016) and 
 17 
this cow was only 40 days in milk. Furthermore, it was shown that cows with mastitis 
induced by Streptococcus uberis have higher IgG concentrations in serum than cows 
with mastitis induced by Staphylococcus aureus (Kociņa et al., 2012). In addition, it is 
not known if this cow had other infections besides the mastitis that could be an 
additional reason for the high IgG concentrations in milk. 
The enzyme LDH in milk is known to increase during a mammary immune re-
sponse and it originates at least partially from soluble LDH in the blood through an 
opening of the blood milk barrier (Lehmann et al., 2013). However, LDH is also re-
leased by damaged cells (Glick, 1969; Lehmann et al., 2013). Thus, the origin of LDH 
in milk shows the opening of the blood-milk barrier on the one hand and the 
increased number of leukocytes in milk (Kato et al., 1989) and cell damage in the 
udder (Bogin et al., 1977; Zank & Schlatterer, 1998) on the other hand. This leads to 
correlations between the LDH activity in milk and SCC during mastitis, which was 
also shown in this field study. As the opening of the blood-milk barrier and the 
increase of SCC during mastitis is dependent on the involved pathogen (Barkema et 
al., 1998; Wellnitz et al., 2011, 2016) this also explains why this correlation was found 
in infections with most of the pathogens but not in Staphylococcus aureus induced 
mastitis. Furthermore, the correlation between LDH activity and IgG concentration in 
milk were different in quarters infected with different pathogens. The correlations 
were similar with results found by Hernàndez-Castellano et al. (2017) in 
Corynebacterium bovis, Staphylococcus aureus, and Streptococcus uberis infected 
quarters. In quarters infected with Gram-negative bacteria, highest SCC were 
expected (Barkema et al., 1998). The tremendous increase of SCC can lead to the 
higher LDH activity in milk from quarters infected with Gram-negative compared to 
those with Gram-positive bacteria. Furthermore, Gram-negative bacteria are 
assumed to impair the blood-milk barrier to a greater extent than Gram-positive 
bacteria (Wellnitz et al., 2013) which leads to an increased transfer of LDH from 
blood into milk. This also explains the high LDH concentrations in milk from Gram-
negative infected quarters. Interestingly, also in quarters infected with Streptococcus 
uberis und Streptococcus dysgalactiae high LDH concentrations were found which is 
likely associated with the strong increase of SCC but can also indicate a relevant 
disruption of the blood milk barrier and/or tissue damage.  
As LDH activity in milk has been considered as an indicator of udder health 
(Chagunda et al., 2006) it could be used in automatic milking systems to monitor 
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mastitis. The results show, however, that LDH is not a good marker for all mastitis 
pathogens to detect infections but clearly indicates severe mastitis with high SCC 
and tissue damage. Furthermore, the measurement of LDH activity to predict high 
IgG concentrations in milk, which could be important for the course of the disease, is 
not useful for all common mastitis pathogens. 
Clots and flakes in milk were mainly found in quarters that were infected with 
Streptococcus uberis and Escherichia coli. These bacteria are known to induce 
severe mastitis. Therefore, the treatment with high dosages of OT does not seem to 
be a sufficient therapy to treat mastitis; however, supportive effects on cure rates are 
possible and should be further investigated. 
 
 
CONCLUSIONS 
 
The present study proves that changes of blood components like SCC, LDH, and IgG 
in milk during mastitis of dairy cows are pathogen dependent. The treatment of 
spontaneously occurring mastitis with high dosages of oxytocin does not sufficiently 
increase the IgG concentrations in milk to assume a positive effect on mastitis cure 
rates if antibodies against the involved pathogen are available. Solely in healthy 
quarters an increase of IgG was induced by OT but not in infected glands when 
treatment was performed during an already ongoing infection. Furthermore, an 
increase of SCC in response to injection of high dosages of OT, which could have a 
positive effect on the elimination of specific bacteria, could not be seen in this study. 
Obviously, the effects of OT in supraphysiological dosages on mastitis depend on the 
stage of the disease at which the injections are performed. 
The results of this field study show that the treatment of mastitis with high 
dosages of OT as a stand-alone therapy in the field is obviously not sufficient. 
However, positive effects of high doses of oxytocin on mastitis cure rates cannot be 
excluded and should be further investigated. 
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Table 1: Type (Pathogen), number (n), percentage of bacteria and mean somatic cell 
count (SCC) of infected udder quarters and number of animals treated with oxytocin 
(OT); bacteria were detected in 161 out of 700 examined quarters of 184 cows on 
day 1 (=day of diagnosis of clinical mastitis). 
 
  
Pathogen n % OT (n) 
SCC 
(cells x 1000/mL) 
Corynebacterium bovis 14 2.0 10 1,210 ± 308 
Escherichia coli 7 1.0 2 >3,000 
Staphylococcus aureus 35 5.0 18 1,389 ± 185 
other Staphylococcus 39 5.6 25    691 ± 123 
Streptococcus dysgalactiae 17 2.4 6 1,957 ± 289 
Streptococcus uberis 44 6.3 12 1,676 ± 186 
Klebsiella 1 0.1 0  2,400 
Yeast 1 0.1 1  >3,000 
Streptococcus agalactiae 1 0.1 0  >3,000 
Trueperella pyogenes 1 0.1 0  >3,000 
Gram-positive rods 1 0.1 0    253 
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Table 2: Somatic cell count (cells x 1000/mL) of udder quarters (n) in different pathogen and treatment groups (with oxytocin; without 
oxytocin) on different days relative to clinical diagnosis of mastitis (= day 1); *: number of quarters with SCC > 3’000’000/mL. 
 
 
with oxytocin without oxytocin 
Pathogen n day 1 day 2 day 14 day 28 n day 1 day 2 day 14 day 28 
Corynebacterium bovis 9 
5.95 ± 0.17 
*2 
5.91 ± 0.17 
*0 
5.68 ± 0.19 
*1 
5.26 ± 0.30 
*0 
5 
5.63 ± 0.22 
*1 
5.55 ± 0.28 
*1 
5.37 ± 0.14 
*0 
4.97 ± 0.24 
*0 
Staphylococcus aureus 19 
5.18 ± 0.17 
*4 
5.71 ± 0.10 
*3 
5.81 ± 0.13 
*0 
5.97 ± 0.13 
*3 
16 
5.90 ± 0.16 
*1 
5.89 ± 0.15 
*2 
5.79 ± 0.16 
*1 
5.65 ± 0.22 
*0 
other Staphylococcus spp. 25 
5.54 ± 0.10 
*1 
5.81 ± 0.09 
*1 
5.37 ± 0.13 
*0 
5.46 ± 0.15 
*3 
14 
5.64 ± 0.17 
*1 
5.96 ± 0.10 
*2 
5.57 ± 0.13 
*1 
5.58 ± 0.15 
*0 
Streptococcus uberis 20 
6.06 ± 0.17 
*12 
6.08 ± 0.16 
*8 
5.75 ± 0.20 
*4 
5.94 ± 0.27 
*2 
25 
5.86 ± 0.12 
*6 
5.94 ± 0.10 
*4 
5.75 ± 0.11 
*1 
5.91 ± 0.13 
*1 
Streptococcus dysgalcatiae 6 
5.73 ± 0.38 
*2 
5.81 ± 0.22 
*1 
5.62 ± 0.25 
*0 
5.46 ± 0.26 
*0 
11 
6.23 ± 0.12 
*6 
6.28 ± 0.17 
*4 
5.80 ± 0.18 
*1 
6.15 ± 0.13 
*2 
Gram-negative 2 
- 
*2 
- 
*1 
- 
*0 
- 6 
6.46 ± 0.02 
*5 
6.35 ± 0.08 
*4 
5.65 ± 0.29 
*1 
- 
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Table 3: Lactate dehydrogenase activity (U x 1000/L) in mastitis milk of udder quarters (n) in different pathogen and treatment groups 
(with oxytocin; without oxytocin) on different days relative to clinical diagnosis of mastitis (= day 1).
 
with oxytocin without oxytocin 
Pathogen n  day 1 day 2 day 3 day 14 day 28 n  day 1 day 2 day 3 day 14 day 28 
Corynebacterium bovis 9 0.77 ± 0.46  3.28 ± 2.07 2.01 ± 1.37 - - 5 0.20 ± 0.09 0.23 ± 0.11 0.20 ± 0.09 - - 
Staphylococcus aureus 19 0.62 ± 0.18 0.77 ± 0.25 0.61 ± 0.17 1.48 ± 1.25 0.54 ± 0.23 16 1.13 ± 0.68 3.19 ± 2.81 0.38 ± 0.12 0.23 ± 0.09 0.43 ± 0.15 
other Staphylococcus spp. 17 0.39 ± 0.14 0.73 ± 0.29 0.49 ± 0.17 0.13 ± 0.03 0.12 ± 0.04 10 0.58 ± 0.31 0.47 ± 0.22 0.55 ± 0.25 0.10 ± 0.01 0.26 ± 0.05 
Streptococcus uberis 20 2.85 ± 0.75 3.30 ± 0.83 1.88 ± 0.48 0.67 ± 0.25 0.87 ± 0.30 25 1.32 ± 0.43 1.37 ± 0.40 1.16 ± 0.31 1.77 ± 0.90 - 
Streptococcus dysgalcatiae 6 1.55 ± 0.15 1.71 ± 0.91 1.36 ± 0.51 0.37 ± 0.05 - 11 4.04 ± 1.75 5.48 ± 2.11 5.72 ± 2.36 1.58 ± 0.70 0.47 ± 0.13 
Gram-negative 2 - - - - - 6 3.21 ± 1.55 7.79 ± 3.10 8.33 ± 2.46 4.93 ± 2.82 - 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Immunoglobulin G concentrations in milk on days 1 (= day of clinical 
diagnosis of mastitis), 2, and 3 in udder quarters infected with different pathogens 
(C. bovis = Corynebacterium bovis, S. aureus = Staphylococcus aureus, 
S. dysgalactiae = Streptococcus dysgalactiae, other Staph = other Staphylococcus 
than Staphylococcus aureus, S. uberis = Staphylococcus uberis) with (A) or without 
(B) oxytocin treatment; values are means + SD; n = number of quarters.
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